Langleben D - Search Results

1

The Paradox of Pulmonary Vascular Resistance: Restoration of Pulmonary Capillary Recruitment as a Sine Qua Non for True Therapeutic Success in Pulmonary Arterial Hypertension.

Langleben D, Orfanos SE, Fox BD, Messas N, Giovinazzo M, Catravas JD. Langleben D, et al. J Clin Med. 2022 Aug 5;11(15):4568. doi: 10.3390/jcm11154568. J Clin Med. 2022. PMID: 35956182 Free PMC article.

2

Pulmonary endothelin-1 clearance in human pulmonary arterial hypertension.

Langleben D, Dupuis J, Hirsch A, Giovinazzo M, Langleben I, Khoury J, Ruel N, Caron A. Langleben D, et al. Among authors: langleben i. Chest. 2005 Dec;128(6 Suppl):622S. doi: 10.1378/chest.128.6_suppl.622S. Chest. 2005. PMID: 16373881 No abstract available.

3

Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension.

Langleben D, Dupuis J, Langleben I, Hirsch AM, Baron M, Senécal JL, Giovinazzo M. Langleben D, et al. Among authors: langleben i. Chest. 2006 Mar;129(3):689-95. doi: 10.1378/chest.129.3.689. Chest. 2006. PMID: 16537869

4

Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.

Langleben D, Orfanos SE, Giovinazzo M, Hirsch A, Baron M, Senécal JL, Armaganidis A, Catravas JD. Langleben D, et al. Arthritis Rheum. 2008 Apr;58(4):1156-64. doi: 10.1002/art.23405. Arthritis Rheum. 2008. PMID: 18383374 Free article.

5

Effects of bone morphogenic proteins and transforming growth factor-beta on In-vitro production of endothelin-1 by human pulmonary microvascular endothelial cells.

Star GP, Giovinazzo M, Langleben D. Star GP, et al. Among authors: langleben d. Vascul Pharmacol. 2009 Jan-Feb;50(1-2):45-50. doi: 10.1016/j.vph.2008.09.001. Epub 2008 Sep 24. Vascul Pharmacol. 2009. PMID: 18849010

6

Bone morphogenic protein-9 stimulates endothelin-1 release from human pulmonary microvascular endothelial cells: a potential mechanism for elevated ET-1 levels in pulmonary arterial hypertension.

Star GP, Giovinazzo M, Langleben D. Star GP, et al. Among authors: langleben d. Microvasc Res. 2010 Dec;80(3):349-54. doi: 10.1016/j.mvr.2010.05.010. Epub 2010 Jun 4. Microvasc Res. 2010. PMID: 20594999

7

Systemic sclerosis and early-onset pulmonary hypertension.

Langleben D, Orfanos SE. Langleben D, et al. Chest. 2010 Jul;138(1):238-9. doi: 10.1378/chest.10-0501. Chest. 2010. PMID: 20605834 No abstract available.

8

Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension.

Shimony A, Eisenberg MJ, Rudski LG, Schlesinger R, Afilalo J, Joyal D, Dragatakis L, Hirsch A, Boutet K, Fox BD, Langleben D. Shimony A, et al. Among authors: langleben d. Am J Cardiol. 2011 Aug 1;108(3):460-4. doi: 10.1016/j.amjcard.2011.03.066. Epub 2011 May 19. Am J Cardiol. 2011. PMID: 21600533

9

Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension.

Fox BD, Shimony A, Langleben D. Fox BD, et al. Among authors: langleben d. Am J Cardiol. 2011 Oct 15;108(8):1177-82. doi: 10.1016/j.amjcard.2011.06.021. Epub 2011 Aug 23. Am J Cardiol. 2011. PMID: 21864815 Review.

10

Incidence and significance of pericardial effusion in patients with pulmonary arterial hypertension.

Shimony A, Fox BD, Langleben D, Rudski LG. Shimony A, et al. Among authors: langleben d. Can J Cardiol. 2013 Jun;29(6):678-82. doi: 10.1016/j.cjca.2012.04.009. Epub 2012 Jun 19. Can J Cardiol. 2013. PMID: 22717247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters